Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

"Clear and precise" SOPs should be part of corporate compliance audit programs -- FDAer.

This article was originally published in The Tan Sheet

Executive Summary

CORPORATE COMPLIANCE AUDIT PROGRAMS SHOULD HAVE "CLEAR AND PRECISE" SOPs for all manufacturing procedures and practices, including all possible "don'ts," FDA Office of Enforcement Deputy Director Arvin Shroff, PhD, told a Food & Drug Law Institute meeting July 11. The recommendations were included in Shroff's unofficial list of "points to consider" for auditing programs. Many standard operating procedures (SOPs) "are written so broadly just to appease FDA...that you can almost drive a truck through it," Shroff remarked. "When you write a very broad SOP, you can run into problems yourselves -- your own employees can misuse them," he warned.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084037

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel